We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated

Around 80% to 85% of those cases are a type of lung cancer called non-small cell lung cancer. Overall, lung cancer is the second-most common cancer next to breast cancer in women and prostate cancer in men. The data will be presented Monday morning at the ...

'We are going to have lung cancer patients living longer and better': A new kind of cancer treatment is about to change how we treat the disease

About 80% to 85% of them are non-small-cell lung cancer, on which these trials focused. Overall, lung cancer is the second-most common cancer among Americans, next to breast cancer in women and prostate cancer in men. Immunotherapy is a competitive field.